On Strategy Showcase

Episode: How this Grand Effie winner fought generics and held its price premium

Host: Fergus O’Carroll
Guests: Mel Arrow (CEO, McCann London), Joss Major (Strategy Partner, McCann London)
Date: March 22, 2026

Episode Overview

This episode delves into the story behind Nurofen's "Gender Pain Gap" campaign—the Grand Effie-winning strategy that helped the premium pain-relief brand maintain its price premium in the face of fierce generic competition and a declining category. Host Fergus O’Carroll interviews Mel Arrow and Joss Major from McCann London, exploring how the agency shifted Nurofen's brand positioning from functional superiority to emotional resonance and societal purpose. The episode offers a deep dive into the strategic, creative, and cultural factors that drove real-world effectiveness.

Key Discussion Points & Insights

Background: The Challenge Facing Nurofen

• Category Context:
  • Nurofen, long established as the leading ibuprofen brand in the UK, faces a market where 60% of sales are own brand/private label [08:00].
  • Nurofen commands a 3–5x price premium over generics but was hit by negative media and consumer skepticism about whether branded products justified higher prices [10:00].
  • "To try and prove that you are worth paying more... when the news and the popular media is against you was a really tough starting point..." — Joss Major [10:00].
• Initial Brand Response:
  • Doubled down on category tropes—innovation (new formulas, liquid capsules) and speed ("Nurofen Express") [11:11].

The Strategic Pivot

• Insight: Rational vs. Emotional Needs

  • Recognition that, despite being seen as the fastest, sales and value share were in decline [12:05].
  • Research revealed that empathy, not speed, was the brand's weakest metric—and a wider category problem [14:02].
  • "Pain is something that is deeply personal, deeply emotional and subjective. Why should the category drivers be just rational?" — Joss Major [14:06].

• Testing the Theory:

  • Commissioned research proved empathy was the real gap [15:19].
  • "At every stage of this story, there is a rational proof at the heart of every decision... going after emotion, but still backed up with really rational, scientific proof." — Mel Arrow [15:19].

Understanding the Audience

• Gendered Consumption Patterns

  • 60% of category purchasers are women, due to both personal pain experiences and caregiving roles [16:21].
  • Nurofen's previous tone and tropes (speedboats, racing)—inadvertently masculine—alienated women [19:23].
  • AI imagery of brand perceptions generated a "sharp-suited man... aloof, detached" [17:53].

• Empathy as a Category-Wide Blindspot

  • 70% of people felt brands don't understand their pain [17:53].
  • Empathy was lacking across all brands, not just Nurofen.

Societal Impact: The Gender Pain Gap

• What is the Gender Pain Gap?
  • The term, discovered in literature and made famous by the campaign, refers to consistent underestimation and dismissal of women's pain by the medical community and society at large [28:34].
  • "Women's pain is often overlooked or dismissed, or women are outright gaslit by medical professionals." — Mel Arrow [28:34].
  • 1 in 2 women in the UK report having their pain dismissed [30:30].
• Examples of Social Impact:
  • From Serena Williams' birth story to everyday exchanges, the issue is universal [30:30].

The Big Leap: From Functional to Purpose-Driven

• Purpose-Driven Transformation
  • The campaign repositioned Nurofen not just as a functional product but as a leader in "pain" and societal conversation [22:37].
  • "Nurofen has really embraced the idea of being a purpose-driven brand. Internally... all the way through to marketing and advertising." — Mel Arrow [22:37].
  • Movement included partnerships, research, tools for GP visits, and policy work alongside comms [41:23].

Testing, Measurement & Execution

• Test & Learn Approach

  • Ran controlled regional econometric tests, using the new "See My Pain" platform versus traditional speed messaging [25:22].
  • "See my pain" communications were 5x more effective at driving short-term sales than old speed-focused work [25:22].

• Integrated, Multi-Channel Rollout

  • Beyond TV and social, included:
    • GP surgery training
    • Behavioral tools for patients
    • Pop-up pharmacies and social experiments [26:42; 34:49].

• Creative Execution

  • Central device: Fake pain relief packs replaced pills with women's real pain dismissal quotes ("you're just being emotional," "it's all in your head") [34:19].
  • "It becomes very difficult to argue when you use women's real stories." — Joss Major [34:19].

Results & Ongoing Impact

• Brand and Business Return
  • Year 1: Sales decline halted, brand trust and empathy metrics rose quickly [38:52].
  • "Other brands continued to lose out to own brand... this was the first year we began to see Nurofen winning back share... from own brand as well." — Joss Major [39:43].
  • Year 2 and 3: 15% increase in value sales after five years of decline [39:43].
• Long-Term Commitment
  • Ongoing research, partnerships with universities and the NHS, new behavioral tools ("pain pass") [41:23].
  • Expansion into policy advocacy; launching immersive social experiments in 2026 to deepen empathy [41:23].

Industry Reflections

• Effectiveness of Networks vs. Independents
  • Mel Arrow encourages recognition of the work done at network agencies like McCann as much as cutting-edge independents [44:47]:
  • "There are incredibly talented people in network agencies making incredible work... Effie's Agency of the year... winning for Xbox, Nurofen, the Electoral Commission, Dettol..." — Mel Arrow [45:58].

Notable Quotes & Memorable Moments

• "Pain is something that is deeply personal, deeply emotional and subjective. Why should the category drivers be just rational?"
  — Joss Major [14:06]

• "Every campaign drives sales, but sales isn't enough. It comes down to this issue of price... what is the emotional connection you're creating in a woman's mind that makes her willing to pay three, four, five times more?"
  — Fergus O’Carroll [20:09]

• "We set out to build a long-term brand platform that could drive sales in the longer term. But the short-term impact... was way beyond what we'd expected."
  — Joss Major [25:22]

• "Being able to name something... the gender pain gap... that people can't quite put their finger on in society but know is real—that’s one of the strongest elements of this campaign."
  — Mel Arrow [28:34]

• "One in two women in the UK have felt their pain has been dismissed... even professional athletes like Serena Williams. It’s a mind-blowing field once you dive in."
  — Joss Major [30:30]

• "It was crucial to get the tone right—acknowledge women’s anger and frustration without alienating healthcare professionals who also struggle in the system."
  — Joss Major [32:04]

• "This is not an anti-independent agency message. But there’s a bias... the best work comes only from independents. I see, day to day, that network agencies are making incredible work."
  — Mel Arrow [44:47]

Timestamps for Key Segments

• Intro & Effie context: [00:00–05:45]
• Agency leadership & strategy skills: [05:45–07:44]
• Category, competitive challenge & price premium: [08:00–10:00]
• Original brand response: [11:11]
• The decision to pivot: [12:05]
• Uncovering the empathy gap: [14:02–15:19]
• Gendered category insight: [16:08–17:53]
• Brand perceptions & masculine tropes: [17:53–20:09]
• Price premium, trust, and role of purpose: [20:53–22:37]
• Testing, pilot execution, and proof: [25:10–26:42]
• Media mix and non-traditional activation: [26:42–28:26]
• Defining the gender pain gap: [28:34–30:27]
• Societal/medical dismissal of women’s pain: [30:30–34:05]
• Creative execution: fake pain packs: [34:19–35:57]
• Film and cultural activations: [36:30–38:19]
• Brand and commercial results: [38:52–40:55]
• Campaign evolution & ongoing work: [41:23–43:57]
• Industry reflection: networks vs. independents: [44:47–45:58]

Conclusion

This episode offers a masterclass in brand transformation—showcasing how Nurofen shifted from rational, functional messaging to an emotionally resonant, purpose-driven strategy that addressed a real societal issue. With carefully measured steps, consistent creative execution, and a willingness to confront bias, Nurofen not only stabilized but grew in a declining market, proving the enduring power of insight-led, empathetic marketing.